Table 2.
MCDM methods and the frequency of their usage in COVID-19 pandemic.
| MCDM method | Number of paper |
Total | Fuzzy papers | Crisp papers | |
|---|---|---|---|---|---|
| Fuzzy | Crisp | ||||
| AHP | 16 | 11 | 27 | Razzaq et al. [8 ], Altay et al. [71 ], Palouj et al. [144 ], Chen and Wang [143 ], Hezam et al. [135 ], Ghorui et al. [131 ], Özkan et al. [10 ], Yao [130 ], Boyacıand Şişman [126 ], Choudhury et al. [124 ], Chen and Lin [107 ], Belhadi et al. [106 ], Das et al. [115 ], Orji and Ojadi [152 ], Sharma et al. [157 ] | Khurana et al. [9 ], Gao et al. [137 ], Hartanto and Mayasari [136 ], Ortiz-Barrios et al. [129 ], Shadeed and Alawna [128 ], Mohammed et al. [122 ], Albahri et al. [148 ], Requia et al. [110 ], Das et al. [154 ], Bragatto et al. [159 ] |
| TOPSIS | 11 | 7 | 18 | Ashraf and Abdullah [103 ], Chen and Lin [107 ], Ashraf et al. [109 ], Alkan and Kahraman [112 ], Majumdar et al. [116 ], Aydin and Seker [120 ], Chai et al. [127 ], Ghorui et al. [131 ], Hezam et al. [135 ], Chen and Wang [143 ], Ocampo et al. [119 ] | Mohammed et al. [108 ], Albahri et al. [111 ], Hezer et al. [113 ], Mohammed et al. [122 ], Boyacıand Şişman [126 ], Ortiz-Barrios et al. [129 ], Yamagishi and Ocampo [132 ] |
| VIKOR | 9 | 3 | 12 | Razzaq et al. [8 ], Khan et al. [16], [17], Yao [130 ], Shah et al. [121 ], Manupati et al. [77 ], Hosseini et al. [114 ], Belhadi et al. [106 ], Kirişci et al. [70 ], Samanci et al. [145 ] | Hezer et al. [113 ], Albahri et al. [148 ], Wan et al. [93 ] |
| DEMATEL | 8 | 2 | 10 | Ocampo and Yamagishi [104 ], Hosseini et al. [114 ], Shah et al. [121 ], Lin et al. [5], [6], Asadi et al. [139 ], Paul et al. [140 ], Alam et al. [141 ], Shanker et al. [142 ] | Altuntas and Gok [76 ], Das et al. [154 ] |
| BWM | 4 | 2 | 6 | Aydin and Seker [120 ], Kumar et al. [133 ], Petrudi et al. [134 ], Wan et al. [93 ] | Ahmad et al. [24 ], Kumar and Kumar Singh [138 ] |
| GRA | 4 | – | 4 | Ashraf and Abdullah [103 ], Petrudi et al. [134 ], Si et al. [149 ], Mehmood et al. [151 ] | – |
| MULTIMOORA | 3 | 1 | 4 | Saraji et al. [117 ], Özkan et al. [10 ], Xiaozhen et al. [158 ] | Orji and Ojadi [152 ] |
| SWARA | 2 | 1 | 3 | Mardani et al. [102 ], Saraji et al. [117 ] | Sharma et al. [105 ] |
| COPRAS | 2 | 1 | 3 | Ashraf et al. [109 ], Goker [125 ] | Hezer et al. [113 ] |
| DEA | 1 | 2 | 3 | Aydin and Yurdakul [79 ] | da Silveira Pereira and de Mello [12 ], Revuelta et al. [150 ] |
| FODSM | 2 | – | 2 | Albahri et al. [147 ], Alsalem et al. [146 ] | – |
| FWZIC | 2 | – | 2 | Albahri et al. [147 ], Alsalem et al. [146 ] | – |
| ANP | 2 | – | 2 | Shanker et al. [142 ], Shah et al. [121 ] | – |
| WASPAS | 2 | – | 2 | Mardani et al. [102 ], Sharma et al. [157 ] | – |
| MARCOS | 1 | – | 1 | Ecer and Pamucar [118 ] | – |
| ARAS | 1 | – | 1 | Mishra et al. [123 ] | – |
| SODOSM | – | 1 | 1 | – | Albahri et al. [73 ] |
| TISM | 1 | – | 1 | Karmaker et al. [153 ] | – |
| OPA | 1 | – | 1 | Mahmoudi et al. [155 ] | – |
| GLDS | 1 | – | 1 | Wen and Liao [156 ] | – |